Live Breaking News & Updates on Oceanpine Capital

Stay updated with breaking news from Oceanpine capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Sanofi, Pfizer, Acelyrin and more—Chutes & Ladders

Sanofi, Pfizer, Acelyrin and more—Chutes & Ladders
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

New York , United States , City Of , United Kingdom , Eric Green , Anita Scheuber , Michael Harvey , Max Bayer , Andrew Baum , Marc Becker , Danielle Meyrick , Michael Chen , Steve Labkoff , Julie Oshaughnessy , Shephard Mpofu , Stacy Lindborg , Inversago Pharma , Scott Harris , Yingyong Xu , Sanam Pangali , Gabrielle Masson , Dave Chenn , Shao Lee Lin , Ronny Gal , Erik Ingelsson , Albert Bourla ,

YS Biopharma to Hold Extraordinary General Meeting on May 21, 2024 and Announces the Appointment of Interim Chief Executive Officer

YS Biopharma to Hold Extraordinary General Meeting on May 21, 2024 and Announces the Appointment of Interim Chief Executive Officer
balticbusinessnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from balticbusinessnews.com Daily Mail and Mail on Sunday newspapers.

Hong Kong , United States , Dave Chenn , Hui Shao , China Century Group , Meeting Of The Company , Company The Board , Lakeshore Biopharma Co Ltd , China Green Energy Fund , Institute Of Technology , Company The Interim , Council Member , University Of Chicago Booth School Business , Ys Biopharma Co Ltd , Rsys Group , Exchange Square , Extraordinary General Meeting , Two Exchange Square , Eastern Time , Incentive Plan , Interim Chief Executive Officer , Chief Executive Officer , Co Chief Executive Officer , Chief Business Officer , Oceanpine Capital , Managing Partner ,

YS Biopharma to Hold Extraordinary General Meeting on May 21, 2024 and Announces the Appointment of Interim Chief Executive Officer

YS Biopharma to Hold Extraordinary General Meeting on May 21, 2024 and Announces the Appointment of Interim Chief Executive Officer
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United States , Hong Kong , Robin Yang , Hui Shao , Alyssa Li , Dave Chenn , Rsys Group , Lakeshore Biopharma Co Ltd , Company The Interim , Council Member , Company The Board , Securities Exchange , University Of Chicago Booth School Business , Company Registration Statement On Form , China Green Energy Fund , China Century Group , Institute Of Technology , Source Ys Biopharma Co Ltd , Meeting Of The Company , Ys Biopharma Co Ltd , Prnewswire Ys Biopharma Co Ltd , Exchange Square , Extraordinary General Meeting , Two Exchange Square , Eastern Time , Incentive Plan ,

YS Biopharma To Hold Extraordinary General Meeting On May 21, 2024 And Announces The Appointment Of Interim Chief Executive Officer

YS Biopharma To Hold Extraordinary General Meeting On May 21, 2024 And Announces The Appointment Of Interim Chief Executive Officer
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Hong Kong , United States , Hui Shao , Dave Chenn , Robin Yang , Alyssa Li , China Green Energy Fund , Exchange Square , Securities Exchange , Company The Interim , Prnewswire Ys Biopharma Co Ltd , Source Ys Biopharma Co Ltd , Company The Board , Council Member , Company Registration Statement On Form , China Century Group , University Of Chicago Booth School Business , Ys Biopharma Co Ltd , Meeting Of The Company , Rsys Group , Lakeshore Biopharma Co Ltd , Institute Of Technology , Extraordinary General Meeting , Two Exchange Square , Eastern Time , Incentive Plan ,

Tencent, Guoxin co-lead $97m Series E round in Chinese biopharma Evopoint

Tencent Investment and Guoxin Investment have jointly led a Series E funding round of 700 million yuan ($97.4 million) in Evopoint Biosciences. ....

Evopoint Biosciences , Jinan Industrial Development Investment Group , Tencent Investment , Guoxin Investment , Yuekai Securitie , Yuekai Capital Investment , Stars Capital , Shanghai Pudong Venture , Loyal Valley Capital , Oceanpine Capital ,